Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution

Affiliations

¹ Department of Oncology, University of Modena e Reggio Emilia, Modena Cancer Centre, Modena, Italy.
² Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Rome, Italy.
³ Medical Oncology Department, Sant'Andrea Hospital, Rome, Italy.
⁴ Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Editorial

Massimiliano Salati et al. Transl Lung Cancer Res. 2018 Apr.

. 2018 Apr;7(Suppl 2):S91-S94.

doi: 10.21037/tlcr.2018.01.14.

¹ Department of Oncology, University of Modena e Reggio Emilia, Modena Cancer Centre, Modena, Italy.
² Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Rome, Italy.
³ Medical Oncology Department, Sant'Andrea Hospital, Rome, Italy.
⁴ Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Horn L, Spigel DR, Vokes EE, Holgado E, Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L, Pluzanski A, Reckamp KL, Burgio MA, Kohlhäeufl M, Waterhouse D, Barlesi F, Antonia S, Arrieta O, Fayette J, Crinò L, Rizvi N, Reck M, Hellmann MD, Geese WJ, Li A, Blackwood-Chirchir A, Healey D, Brahmer J, Eberhardt WEE. Horn L, et al. J Clin Oncol. 2017 Dec 10;35(35):3924-3933. doi: 10.1200/JCO.2017.74.3062. Epub 2017 Oct 12. J Clin Oncol. 2017. PMID: 29023213 Free PMC article. Clinical Trial.

1. Novello S, Barlesi F, Califano R, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:v1-27. 10.1093/annonc/mdw326 - DOI - PubMed
1. Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000;18:2095-103. 10.1200/JCO.2000.18.10.2095 - DOI - PubMed
1. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-97. 10.1200/JCO.2004.08.163 - DOI - PubMed
1. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32. 10.1056/NEJMoa050753 - DOI - PubMed
1. Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 2015;373:123-35. 10.1056/NEJMoa1504627 - DOI - PMC - PubMed